Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase (TDO): Design, Synthesis and Preclinical Evaluation of a Novel TDO Inhibitor.

Eduard Dolušić, Pierre Larrieu, Laurence Moineaux, Vincent Stroobant, Luc Pilotte, Didier Colaux, Benoît Van den Eynde, Bernard Masereel, Johan Wouters, Raphaël Frédérick

Research output: Contribution to journal › Literature review › peer-review

9 Poster
3 Article
1 Conference contribution
1 Paper
More
- 1 Literature review

1 results

Filter

2010

Structural and enzymatic study of tryptophan 2,3-dioxgenase (TDO), a potential target in anticancer immunotherapy.
Moineaux, L., Charlier, C., Dolušić, E., Larrieu, P., Pilotte, L., Colaux, D., Stroobant, V., Galleni, M., Masereel, B., Van den Eynde, B., Wouters, J. & Frédérick, R., 2010, In: Drugs of the future. 35, suppl A, p. 189
Research output: Contribution to journal › Literature review › peer-review